-
Z-DEVD-FMK (SKU A1920): Reliable Caspase-3 Inhibition in Cel
2026-05-18
This article delivers scenario-driven guidance for leveraging Z-DEVD-FMK (SKU A1920) as a robust, irreversible caspase-3 inhibitor in apoptosis and neuroprotection workflows. By addressing real laboratory challenges—ranging from assay reproducibility to vendor selection—we demonstrate how Z-DEVD-FMK provides data-backed advantages in sensitivity, specificity, and workflow clarity.
-
Medroxyprogesterone Acetate: Workflows for Reproductive & Re
2026-05-18
Leverage Medroxyprogesterone acetate (MPA) for robust modeling of steroid hormone signaling, endometrial decidualization, and renal gene regulation. This guide delivers protocol enhancements, troubleshooting insights, and actionable data, highlighting APExBIO’s MPA as a benchmark reagent for advanced translational research.
-
DiscoveryProbe FDA-approved Drug Library: Mechanisms & Evide
2026-05-17
The DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) is a rigorously curated FDA-approved bioactive compound library with 2,320 clinically validated agents for high-throughput research. It enables robust drug repositioning screening and pharmacological target identification across oncology and neurodegenerative disease models. This dossier synthesizes mechanistic scope, evidence, and workflow parameters for optimal integration.
-
Peroxidasin Drives Glioblastoma Glycolysis via LDHA Modulati
2026-05-16
This study identifies peroxidasin (PXDN) as a critical regulator of glycolytic metabolism in glioblastoma, acting through lactate dehydrogenase A (LDHA) to promote malignancy. The findings provide mechanistic insight into tumor bioenergetics and support PXDN as a potential diagnostic and therapeutic target in GBM.
-
CBD Attenuates Orofacial Inflammatory Pain via Multi-Level M
2026-05-15
This study reveals how cannabidiol (CBD) robustly reduces orofacial inflammatory pain and associated affective symptoms in mice. By utilizing behavioral paradigms and molecular profiling, the research details the peripheral and central mechanisms involved, highlighting translational implications for comprehensive pain management.
-
DDX21-SIRT7-NAT10 Axis Drives ac4C Modification in CRC Metas
2026-05-15
The study identifies a mechanistic pathway in colorectal cancer (CRC) where DDX21 competitively binds SIRT7, leading to NAT10 overexpression and enhanced N4-acetylcytidine (ac4C) mRNA modification. This molecular cascade stabilizes key metastasis- and angiogenesis-related transcripts, underlining DDX21 as a promising therapeutic target in advanced CRC.
-
2X Taq PCR Master Mix: Streamlining Genotyping & TA Cloning
2026-05-14
The 2X Taq PCR Master Mix (with dye) revolutionizes molecular biology workflows by enabling direct gel loading and robust DNA amplification. Its streamlined formulation is ideal for rapid genotyping, TA cloning, and high-throughput analysis, minimizing errors and hands-on time.
-
Carbapenemase Genes in CREC: Dynamics and Multidrug Resistan
2026-05-14
This study systematically characterizes the prevalence, genetic localization, and transmission dynamics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) isolates from teaching hospitals in Guangdong, China. The findings reveal high rates of plasmid-borne blaNDM-1 and extensive multidrug resistance, underscoring the threat of rapid horizontal gene transfer in clinical settings.
-
SEMA3E Drives Beige Adipocyte Thermogenesis via β-Catenin Pa
2026-05-13
This study reveals that SEMA3E promotes beige adipocyte differentiation and thermogenesis by modulating β-catenin signaling in mice. The findings clarify upstream regulation of mitochondrial function in adipose tissue, with implications for metabolic disorder research and experimental modeling of thyroid hormone pathways.
-
Technical Guide: EdU Flow Cytometry Assay Kits (Cy5) for S-P
2026-05-13
EdU Flow Cytometry Assay Kits (Cy5) address the challenge of sensitive, denaturation-free detection of S-phase DNA synthesis in cell proliferation studies. Designed for flow cytometry, these kits are optimal for applications requiring high multiplexing and minimal cell disruption, but are not intended for fixed-tissue imaging or settings lacking access to copper-catalyzed click chemistry workflows.
-
MOG (35-55) Peptide: Advancing Autoimmune Encephalomyelitis
2026-05-12
MOG (35-55), a myelin oligodendrocyte glycoprotein peptide, drives reproducible EAE models for multiple sclerosis research by enabling precise immune modulation and neuroinflammation studies. This article delivers workflow enhancements, protocol guidance, and troubleshooting strategies to unlock robust, translational neuroimmunology using APExBIO’s gold-standard peptide.
-
Chloramphenicol: Reliable Antibiotic for Plasmid Selection A
2026-05-12
Chloramphenicol empowers stringent and reproducible plasmid selection workflows in molecular biology, standing out for its precise inhibition of bacterial protein synthesis and high compatibility with resistance monitoring. Backed by recent surveillance studies and high-purity manufacturing from APExBIO, this antibiotic is a cornerstone for robust genetic and antimicrobial research.
-
MiR-519d-3p in Placental Exosomes Drives Immune Imbalance in
2026-05-11
This study reveals that miR-519d-3p, enriched in placenta-derived exosomes from preeclamptic patients, promotes immune intolerance by increasing Jurkat T cell proliferation, suppressing apoptosis, and skewing T cell differentiation toward Th17. These mechanistic insights advance our understanding of preeclampsia pathogenesis and highlight apoptosis assay strategies for dissecting immune dysregulation.
-
V5 Epitope Tag Peptide: Precision Protein Tagging & Detectio
2026-05-11
The V5 Epitope Tag Peptide empowers precise, multiplexed protein detection in advanced workflows. Its robust sequence and high purity drive reproducibility in Western blot, immunoprecipitation, and next-gen imaging. Discover how APExBIO’s V5 tag unlocks new frontiers in protein science.
-
Escitalopram for Antidepressant Research: Optimized Protocol
2026-05-10
Escitalopram (Lexapro) from APExBIO stands out as a high-purity, selective SSRI for advanced antidepressant and anxiolytic activity studies. Explore actionable workflows, troubleshooting strategies, and the latest evidence behind its use in serotonergic signaling and 5-HT reuptake inhibition assays.